Scientific Program

Call for Cases

The ISSVA Debates & Updates Call for Cases and Case Series will be opening soon, and we wanted to reach out to you in advance to prepare your submissions! The official Call for Cases will open in November 2024 and close mid-December 2024.

Debates & Updates Meeting Dynamics
Below is a list of the topics for the presentations. The moderators will be encouraging a debate style presentation. Thus have your cases support one issue and defend it with evidence or real time data. All presentations will be 4 minutes, followed by a 5-minute discussion. Be prepared for lively participation!

Call for Cases and Case Series topics we are seeking include:

• Medical Treatment
  • Agents, single or combined therapy, short- and long-term side effects, treatment on or off study, study endpoints and measurement of effectiveness
• Coagulation Disorders
  • What patients are at risk? What is the evidence? Who needs to be tested?
  • What is evidence for therapy? What is the best therapy?
  • When should these treatments be used? IR procedures? Surgery? For pain?
  • What are the risks of treatment?
• Slow Flow Malformation 
  • Focus on certain Diagnoses: intra muscular venous malformations, FAVA, Vascular malformations involving the knee, foot, or other joints
  • Topics: Surgery vs. IR, cryotherapy, risk to the joint, when is aggressive therapy needed? Other available therapies, QOL issues, cost effectiveness, medical therapy
  • Patient Stories
• Fast Flow Lesion Sessions
  • Focus: Head and Neck AVM, Foot AVM, High flow lesions mimicking AVM (PHOST) others
  • Topics: compare treatment options (IR, Surgical, medical, combined), when is enough...enough? Cost effectiveness, QOL
  • Patient Stories
• Bone lesions (venous, lymphatic)
  • Topics:  When to treat? How to treat? How do we measure response?
• Clinical Follow-up and Observation
  • Is there still a place for this?
  • Patient Stories
• Visceral/bone Vascular Anomalies (Hepatic, vertebral/bone, spleen, kidney)
  •  Pathology
  • Genomics
  • How should these lesions be defined? What is their natural history?
  • Patient Stories
• Multidisciplinary Vascular Anomaly Centers
  • Is there a right way to build this?
• Patient advocacy and family support groups
  • What are their worries and concerns?
  • How are they best included in our meeting structure?